Affiliation:
1. Departments of Microbiology
2. Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea
Abstract
ABSTRACT
To determine whether Korean red ginseng (KRG) has beneficial effects on human immunodeficiency virus type 1 (HIV-1)-infected patients administered highly active antiretroviral therapy (HAART), we analyzed the CD4 T-cell count, viral load, and resistance mutations to HAART in 46 individuals. Thirteen patients harbored resistance mutations at baseline. The study population was divided into two groups: specifically, a group treated with a combination of HAART plus KRG (23 patients) and a group treated with HAART alone (23 patients). The annual increase in CD4 T-cell count in the combination group was significantly higher than that in the group treated with HAART alone (
P
< 0.05). Overall, 21 patients harbored resistance mutations after 3 years of therapy. Following exclusion of 13 patients displaying baseline resistance mutations, 7.1% of patients (1/14) in the combination group and 42.1% (8/19) in the HAART group were identified with resistance mutations. One patient with baseline resistance mutations in the combination group did not display resistance mutations 3 years after HAART therapy. High-level resistance mutations were significantly lower in the combination group than in the group treated with HAART alone. Five patients showed no improvement in viral copy number (26.3% [5/19]) in the combination group and 9 (45.0% [9/20]) showed no improvement in the HAART-only group. Our data support the clinical utility of KRG intake during HAART therapy.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference32 articles.
1. Carpenter, C. C., D. A. Cooper, M. A. Fischl, J. M. Gatell, B. G. Gazzard, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. Montaner, D. D. Richman, M. S. Saag, M. Schechter, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Volberding. 2000. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society—USA Panel. JAMA283:381-390.
2. Centers for Disease Control and Prevention. 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb. Mortal. Wkly. Rep.41(RR-17):1-19.
3. Cho, Y. K., H. S. Sung, H. J. Lee, Y. K. Kim, H. S. Chi, G. J. Cho, and M. W. Kang. 2000. Detection of resistance mutation to lamivudine in HIV-1 infected patients. J. Korean Soc. Microbiol.35:181-190.
4. Cho, Y. K., and H. Sung. 2007. Effects of Korean red ginseng on serum soluble CD8 in HIV-1-infected patients. J. Ginseng Res.31:175-180.
5. Cho, Y. K., and Y. S. Jung. 2008. High frequency of gross deletions in the 5′ LTR and gag regions in HIV type 1-infected long-term survivors treated with Korean red ginseng. AIDS Res. Hum. Retrovir.24:181-193.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献